Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott
PremiumThe FlyRaymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott
12d ago
Abbott initiates clinical trial of its CardioMems in advanced heart failure
Premium
The Fly
Abbott initiates clinical trial of its CardioMems in advanced heart failure
16d ago
Abbott price target raised to $130 from $115 at Mizuho
Premium
The Fly
Abbott price target raised to $130 from $115 at Mizuho
23d ago
Abbott price target raised to $125 from $120 at Jefferies
PremiumThe FlyAbbott price target raised to $125 from $120 at Jefferies
24d ago
Abbott price target raised to $130 from $125 at Stifel
Premium
The Fly
Abbott price target raised to $130 from $125 at Stifel
24d ago
Abbott price target raised to $139 from $135 at BTIG
Premium
The Fly
Abbott price target raised to $139 from $135 at BTIG
24d ago
Abbott says ‘high confidence’ in Q4 EPS, sales forecasts
PremiumThe FlyAbbott says ‘high confidence’ in Q4 EPS, sales forecasts
24d ago
Abbott made ‘several key advancements’ in R&D pipeline in Q3
Premium
The Fly
Abbott made ‘several key advancements’ in R&D pipeline in Q3
24d ago
Abbott expects FX to have less than 1% negative impact on reported Q4 sales
Premium
The Fly
Abbott expects FX to have less than 1% negative impact on reported Q4 sales
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100